In the past trading week (June 17 to 21), US Congress voted in favor of an amendment to prevent the justice department from cracking down on the marijuana industry using federal funds.

A report on the potential value of the marijuana industry by 2024 made headlines, while numbers on tax revenue seen since the legalization of recreational products in Canada also caught attention.


Here’s a closer look at some of the biggest news during last week’s trading period.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

US Congress vote

The US marijuana industry gained a new layer of protection thanks to the passing of a measure to prevent any obstruction from the Department of Justice on legal cannabis programs at the state level.

The amendment approved by the US House of Representatives will be attached to the 2020 fiscal year Commerce-Justice-Science spending bill. Because of the policy, the federal agency won’t be allowed to use any funds for the criminal pursuit of marijuana programs in medically and recreationally legal states.

According to a report from MJBiz Daily on Thursday (June 20), the vote was approved 267 to 165.

New projections on marijuana market value

On Thursday, Arcview Market Research and BDS Analytics indicated that, thanks to growth seen industry wide in 2018, global legal cannabis sales are now projected at US$40 billion by 2024.

“A key takeaway from the report is that highly restrictive regulations and high tax rates are hurting the legal market’s ability to compete with the illicit market,” Tom Adams, managing director and principal analyst for BDS Analytics’ industry intelligence group, said in a press release. “But legalization advocates endorsed our view that all 50 US states can be expected to be medically legal by 2024, and that 20 will have adult-use sales.”

The Canadian recreational cannabis market is expected to grow to US$4.8 million by 2024.

“Investment capital raised by cannabis companies more than quadrupled to US$14 billion in 2018, according to Viridian Capital Advisors,” the research firms indicated in the release.

Canada reports taxes revenues and consumer trends

The Canadian statistics agency issued an update on the financial results the country has seen by way of taxes since the opening of the recreational market on October 17, 2018.

Statistics Canada reported that the government has collected a total of C$186 million in taxes from legal cannabis products sold since the launch of adult-use sales up to the end of March.

In 2019 alone, provincial governments have accumulated C$79 million in excise taxes, while the federal government secured C$19 million of tax revenue.

The government agency also issued a new report on early trends from Canadian consumers, indicating a surprising increase in reported consumers during the first three months of 2019 in Ontario and Quebec. This study was conducted using self-reported data from Canadian consumers.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Market updates

Shoppers Drug Mart, a Loblaw Companies (TSX:L,OTC Pink:LBLCF) subsidiary, announced a new agreement on Monday (June 17) to use a blockchain-based program to track medical cannabis sold through its online platform.

The deal is being done in collaboration with TruTrace Technologies (CSE:TTT,OTC Pink:BKKSF) and will deploy  TruTrace’s StrainSecure technology. The Toronto-based company reached a listing on the Canadian Securities Exchange on June 14.

Ken Weisbrod, vice president of Shoppers Drug Mart, said it’s critical for medical cannabis consumers to know the source of their purchases so that both patients and practitioners can gain another level of certainty on the integrity of the product.

“When a patient takes medication, there is an expectation that it is standardized, and they can expect consistent clinical outcomes and results. Although that’s not always a guarantee within the medical cannabis industry at the moment, we’re hoping this new program can help change that,” the Shoppers executive said.

This past week, investors of multi-state operator Acreage Holdings (CSE:ACRG.U,OTCQX:ACRGF) and Canopy Growth (NYSE:CGC,TSX:WEED) voted their approval on the proposed acquisition arrangement between the two firms, which is set to take place once marijuana becomes federally legal in the US.

“Alongside our international market strategies and US Hemp strategy, we believe the acquisition of Acreage will be a key step in bolstering our position as a truly global company,” Bruce Linton, co-CEO of Canopy Growth, said in a press release.

Shares of Canopy Growth dropped on Friday (June 21) after the company issued its Q4 and fiscal 2019 results, reporting a net loss of just over C$323.3 million for the quarter. The net loss per share for the firm during Q4 was C$0.98, while its net loss per share for the full fiscal year was C$2.57.

As of 12:30 p.m. EDT on Friday, shares of the Canadian cannabis producer had taken hits both in New York, where they dropped 8.51 percent, and Toronto, with a decline of 8.18 percent.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Editorial Disclosure: Acreage Holdings and TruTrace Technologies are clients of the Investing News Network. This article is not paid-for content.

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 
  • Company has received UK Continuing Professional Development (“CPD”) accreditation for its global education platform, Khiron Academy
  • UK medical professionals may now earn CPD credits through Khiron’s medical cannabis education program
  • The Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK, to increase patient access via medical cannabis education
  • As a leading international medical cannabis educator, nearly 1,000 medical professionals in Latin America and the United Kingdom have registered for, or completed, Khiron Academy training

 Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe is pleased to announce it has received UK Continuing Professional Development (“CPD”) accreditation for Khiron Academy, the Company’s global medical cannabis education platform.

Additionally, following its accreditation, the Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK and fellow founding member of Project Twenty21, to increase patient access through medical cannabis education initially. Khiron Academy will be made available to prescribers in the UK that have registered with Cellen’s MedCanHub, an emerging education portal. Cellen is market leader, widely recognized for also launching the UK’s first digital pain clinic, Leva.

Keep reading... Show less

TRACE’s plant-based and alkaline wellness products to expand into key markets of Japan, China and the Philippines

Emerging leader in innovative health and wellness beverages and consumer products, BevCanna Enterprises Inc . ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today its anticipated expansion into the Asia Pacific region, through its wholly-owned subsidiary Naturo Group. After completing a comprehensive market, distribution and partner assessment, the Company intends to initially launch its portfolio of TRACE health and wellness products in the key markets of Japan, China, and the Philippines, through multi-channel distribution outlets including e-commerce, retail, and wholesale.

Keep reading... Show less

Trulieve acquires dispensary permits from Solevo Wellness West Virginia LLC for $650,000

Trulieve Cannabis Corp . (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States and the largest cannabis company in Florida announced today that it acquired Solevo Wellness West Virginia LLC (“Solevo”) and its three West Virginia dispensary permits for $650,000 . Solevo was awarded two permits in Morgantown and one in Parkersburg in January 2021 as part of the West Virginia application process.

Keep reading... Show less

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) a wellness company that develops and sells sustainable, plant-based products, is pleased to announce that it’s Jusu Home and Body line is now available for purchase on Faire Wholesale Marketplace (“Faire” or “www.faire.com”), an online wholesale marketplace valued at US $2.5 billion. Jusu Home and Body products are currently featured in their “New Arrivals” section.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/80230_8c77c54544bf884c_001.jpg

Keep reading... Show less

 Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) today announced that it has retained KCSA Strategic Communications (” KCSA “), a leading New York City -based communications firm.

Keep reading... Show less